Literature DB >> 29955585

To repair or to replace: four decades in the making.

Patpilai Kasinpila1, Y Joseph Woo1.   

Abstract

Year:  2018        PMID: 29955585      PMCID: PMC6015943          DOI: 10.21037/atm.2017.05.22

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN: 2305-5839


× No keyword cloud information.
  9 in total

1.  The contemporary evolution of mitral valve surgery.

Authors:  Y Joseph Woo; Andrew B Goldstone
Journal:  J Thorac Cardiovasc Surg       Date:  2015-10-09       Impact factor: 5.209

2.  Guidelines on the management of valvular heart disease (version 2012).

Authors:  Alec Vahanian; Ottavio Alfieri; Felicita Andreotti; Manuel J Antunes; Gonzalo Barón-Esquivias; Helmut Baumgartner; Michael Andrew Borger; Thierry P Carrel; Michele De Bonis; Arturo Evangelista; Volkmar Falk; Bernard Iung; Patrizio Lancellotti; Luc Pierard; Susanna Price; Hans-Joachim Schäfers; Gerhard Schuler; Janina Stepinska; Karl Swedberg; Johanna Takkenberg; Ulrich Otto Von Oppell; Stephan Windecker; Jose Luis Zamorano; Marian Zembala
Journal:  Eur Heart J       Date:  2012-08-24       Impact factor: 29.983

3.  Long-term survival of patients undergoing mitral valve repair and replacement: a longitudinal analysis of Medicare fee-for-service beneficiaries.

Authors:  Christina M Vassileva; Gregory Mishkel; Christian McNeely; Theresa Boley; Stephen Markwell; Steven Scaife; Stephen Hazelrigg
Journal:  Circulation       Date:  2013-04-08       Impact factor: 29.690

Review 4.  2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.

Authors:  Rick A Nishimura; Catherine M Otto; Robert O Bonow; Blase A Carabello; John P Erwin; Robert A Guyton; Patrick T O'Gara; Carlos E Ruiz; Nikolaos J Skubas; Paul Sorajja; Thoralf M Sundt; James D Thomas; Jeffrey L Anderson; Jonathan L Halperin; Nancy M Albert; Biykem Bozkurt; Ralph G Brindis; Mark A Creager; Lesley H Curtis; David DeMets; Robert A Guyton; Judith S Hochman; Richard J Kovacs; E Magnus Ohman; Susan J Pressler; Frank W Sellke; Win-Kuang Shen; William G Stevenson; Clyde W Yancy
Journal:  J Thorac Cardiovasc Surg       Date:  2014-05-09       Impact factor: 5.209

5.  Twenty-Year Outcome After Mitral Repair Versus Replacement for Severe Degenerative Mitral Regurgitation: Analysis of a Large, Prospective, Multicenter, International Registry.

Authors:  Siham Lazam; Jean-Louis Vanoverschelde; Christophe Tribouilloy; Francesco Grigioni; Rakesh M Suri; Jean-Francois Avierinos; Christophe de Meester; Andrea Barbieri; Dan Rusinaru; Antonio Russo; Agnès Pasquet; Hector I Michelena; Marianne Huebner; Joseph Maalouf; Marie-Annick Clavel; Catherine Szymanski; Maurice Enriquez-Sarano
Journal:  Circulation       Date:  2016-11-29       Impact factor: 29.690

6.  Very long-term survival and durability of mitral valve repair for mitral valve prolapse.

Authors:  D Mohty; T A Orszulak; H V Schaff; J F Avierinos; J A Tajik; M Enriquez-Sarano
Journal:  Circulation       Date:  2001-09-18       Impact factor: 29.690

7.  Survival advantage and improved durability of mitral repair for leaflet prolapse subsets in the current era.

Authors:  Rakesh M Suri; Hartzell V Schaff; Joseph A Dearani; Thoralf M Sundt; Richard C Daly; Charles J Mullany; Maurice Enriquez-Sarano; Thomas A Orszulak
Journal:  Ann Thorac Surg       Date:  2006-09       Impact factor: 4.330

8.  Mitral valve repair for degenerative disease: a 20-year experience.

Authors:  Mani A Daneshmand; Carmelo A Milano; J Scott Rankin; Emily F Honeycutt; Madhav Swaminathan; Linda K Shaw; Peter K Smith; Donald D Glower
Journal:  Ann Thorac Surg       Date:  2009-12       Impact factor: 4.330

9.  Trends in mitral valve surgery in the United States: results from the Society of Thoracic Surgeons Adult Cardiac Surgery Database.

Authors:  James S Gammie; Shubin Sheng; Bartley P Griffith; Eric D Peterson; J Scott Rankin; Sean M O'Brien; James M Brown
Journal:  Ann Thorac Surg       Date:  2009-05       Impact factor: 4.330

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.